Ramesh K. Ramanathan, MD

Director, GI Medical Oncology
Vice Chair of Research
Division of Hematology/Oncology
Mayo Clinic
Phoenix, Arizona

Dr. Ramesh Ramanathan is a medical oncologist and Director of the GI Medical Oncology program and Vice Chair of Research for the Division of Hematology/Oncology at Mayo Clinic, Phoenix, Arizona. He is also the Associate Director of the Early Therapeutics Program for the Mayo Clinic Cancer Center. Dr. Ramanathan holds appointments as a Professor of Medicine at the Mayo Medical School with a joint appointment at the Translational Genomics Research Institute (TGEN). Prior to joining Mayo Clinic, he served as the medical director of the Virginia G. Piper Cancer Center- Clinical Trials Program, in Scottsdale, Arizona from 2007-2014.

Dr. Ramanathan specializes in the treatment of GI cancers with a focus on pancreatic and colon cancers. His research interests are in new drug development. In the last 20 years, Dr. Ramanathan has been involved in the development of a number of new drugs and treatments such as oxaliplatin and nab-paclitaxel for GI cancers. He has published over 160 papers in peer-reviewed journals. He is an executive committee member and the former chair for the pancreatic cancer research group (PCRT) and is a GI committee member for SWOG. Dr. Ramanathan is an editorial board member for Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, and Gastrointestinal Cancer Research, and is an ad hoc reviewer for a number of other journals.

Last modified: July 24, 2017

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2017 MediCom Worldwide, Inc. All rights reserved